Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roser Torra

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Molecular Genetics and Metabolism Reports|August 17, 2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry diseaseDaniel G Bichet, Roser Torra, Eric Wallace, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 19, 2011
Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndromeSheila Santín, Gemma Bullich, Bárbara Tazón-Vega, et al.
Human Vaccines|February 9, 2011
Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, SpainNeus Cardeñosa, Anna Rodés, Núria Follia, et al.
Orphanet Journal of Rare Diseases|February 9, 2022
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?Derralynn A Hughes, Patrício Aguiar, Olivier Lidove, et al.
Nefrologia|November 15, 2019
Recommendations for the management of renal involvement in the tuberous sclerosis complexGema Ariceta, María José Buj, Mónica Furlano, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 31, 2013
Familial chronic interstitial nephropathy with hyperuricaemia caused by the UMOD geneNadia Ayasreh-Fierro, Elisabet Ars-Criach, Vanesa Lopes-Martín, et al.
Medicine|December 9, 2016
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patientsLaia Sans, Julio Pascual, Aleksandar Radosevic, et al.
Molecular Genetics and Metabolism Reports|December 22, 2021
Corrigendum to "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease" [Bichet et al., MGM Reports; 28 (2021) 100786]Daniel G Bichet, Roser Torra, Eric Wallace, et al.
Stem Cell Research|December 17, 2017
Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS)Bernd Kuebler, Begoña Aran, Laia Miquel-Serra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 16, 2010
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndromeSheila Santín, Bárbara Tazón-Vega, Irene Silva, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Molecular Genetics and Metabolism Reports|August 17, 2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry diseaseDaniel G Bichet, Roser Torra, Eric Wallace, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 19, 2011
Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndromeSheila Santín, Gemma Bullich, Bárbara Tazón-Vega, et al.
Human Vaccines|February 9, 2011
Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, SpainNeus Cardeñosa, Anna Rodés, Núria Follia, et al.
Orphanet Journal of Rare Diseases|February 9, 2022
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?Derralynn A Hughes, Patrício Aguiar, Olivier Lidove, et al.
Nefrologia|November 15, 2019
Recommendations for the management of renal involvement in the tuberous sclerosis complexGema Ariceta, María José Buj, Mónica Furlano, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 31, 2013
Familial chronic interstitial nephropathy with hyperuricaemia caused by the UMOD geneNadia Ayasreh-Fierro, Elisabet Ars-Criach, Vanesa Lopes-Martín, et al.
Medicine|December 9, 2016
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patientsLaia Sans, Julio Pascual, Aleksandar Radosevic, et al.
Molecular Genetics and Metabolism Reports|December 22, 2021
Corrigendum to "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease" [Bichet et al., MGM Reports; 28 (2021) 100786]Daniel G Bichet, Roser Torra, Eric Wallace, et al.
Stem Cell Research|December 17, 2017
Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS)Bernd Kuebler, Begoña Aran, Laia Miquel-Serra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 16, 2010
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndromeSheila Santín, Bárbara Tazón-Vega, Irene Silva, et al.
Pageof 17